Compare BioNTech SE - ADR (BNTX) vs Strategy Inc. (MSTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Strategy Inc. — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Strategy Inc. trades at $97.44 (market cap $37.84B). The key difference: Strategy Inc. is the larger of the two by market cap, and BioNTech SE - ADR is trading nearer its 52-week high, Strategy Inc. nearer its low. Which is the better fit depends on your goals.
| BNTX | MSTR | |
|---|---|---|
Market Cap | $23.31B | $37.84B |
Sector | Health | Technology |
52-Week High | $119.34 | $394.39 |
52-Week Low | $83.89 | $82.31 |
Enterprise Value | $6.60B | $56.61B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Strategy Inc.
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →
